N.H. Admin. Code § Ph 2201.01

Current through Register No. 50, December 12, 2024
Section Ph 2201.01 - Definitions

In addition to RSA 318:1, the following definitions shall apply to this chapter:

(a) "Board investigator" means a pharmacist employed by the pharmacy board to investigate violations of the pharmacy laws or the rules of the pharmacy board by a person licensed at the time the alleged violation occurred;
(b) "Confidential letter of concern" means a warning letter issued by the pharmacy board to a licensee as a type of outcome to an investigation conducted by the pharmacy board investigators;
(c) "Drug diversion" means the illegal distribution of prescription controlled drugs, or transfer of any legally prescribed controlled substance from the individual for whom it was prescribed to another person for any illicit use;
(d) "Facility" means any pharmacy, hospital, clinic, practitioner offices, methadone clinic, orveterinarian clinic that have medication on their premises and are inspected by the pharmacy board;
(e) "Infusion center" means a place, usually outpatient, where patients can receive intravenous infusions and therapeutic injections in a safe, professional, and comfortable environment;
(f) "Licensee" means any entity or individual which is licensed, certified, registered, or regulated by the pharmacy board or a board whose licensees are subject to investigation under RSA 318:30;
(g) "Medication error" means any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the healthcare professional or patient. Such events can be related to professional practice, healthcare products, procedures, and systems including prescribing, order communication, product labeling, packaging and nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use.
(h) "Methadone clinic" means a clinic which has been established for the dispensing of methadone, a drug under the Controlled Substance Act, for the purpose of treating addiction disorder;
(i) "Naturopathic medicine" means "naturopathic medicine" as defined in RSA 328-E:2, IX, namely, "a system of primary health care practiced by doctors of naturopathic medicine for the prevention, diagnosis, and treatment of human health conditions, injuries, and disease that uses education, natural medicines, and therapies to support and stimulate the individual's intrinsic self-healing processes;"
(j) "Nurse practitioner" means a registered nurse currently licensed by the board under RSA 326-B:18. The term includes "advanced practice registered nurse (APRN).;
(k) "Professional misconduct" means behavior by a professional that implies an intentional compromise of ethical standards, including the acts specified in RSA 318:29, II;
(l) "Quality related event (QRE)" means the incorrect dispensing of a prescribed medication that is received by a patient, including a variation from the prescriber's prescription order, or failure to identify and manage errors identified during a drug utilization review; and
(m) "Tele-pharmacy service" means the delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with a pharmacist.

N.H. Admin. Code § Ph 2201.01

Derived from Volume XL Number 11, Filed March 12, 2020, Proposed by 12997, Effective 3/5/2020, Expires 3/5/2030.